Triangle of Trust in Cancer Care? The Physician, the Patient, and Artificial Intelligence Chatbot.

IF 2.4 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL Cancer Biotherapy and Radiopharmaceuticals Pub Date : 2023-11-01 Epub Date: 2023-09-14 DOI:10.1089/cbr.2023.0112
J Harvey Turner
{"title":"Triangle of Trust in Cancer Care? The Physician, the Patient, and Artificial Intelligence Chatbot.","authors":"J Harvey Turner","doi":"10.1089/cbr.2023.0112","DOIUrl":null,"url":null,"abstract":"<p><p>Trust, as a philosophic paradigm, is predominantly interpersonal, between human beings, and is differentiated from reliance. Can a person trust an inhumane amoral agent, such as a large language model artificial intelligence (AI) chatbot, to manifest the goodwill and willingness normally required in order for it to be deemed trustworthy? This article explores the relationship between the cancer patient, their physician, and AI chatbot in a proposed tripartite, consultative, personalized approach to shared-care in precision molecular oncology. It examines the nature of trust between human agents and machines. It also contemplates AI-enhanced technical precision in state-of-the-art cancer management, complemented by trustworthy, holistic clinical care by a physician, for each individual patient. \"<i>To what extent can the user</i> \"<i>trust</i>\" <i>GPT-4?</i>\" Peter Lee,<sup>1</sup> Microsoft Research 2023.</p>","PeriodicalId":55277,"journal":{"name":"Cancer Biotherapy and Radiopharmaceuticals","volume":" ","pages":"581-584"},"PeriodicalIF":2.4000,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Biotherapy and Radiopharmaceuticals","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1089/cbr.2023.0112","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/9/14 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Trust, as a philosophic paradigm, is predominantly interpersonal, between human beings, and is differentiated from reliance. Can a person trust an inhumane amoral agent, such as a large language model artificial intelligence (AI) chatbot, to manifest the goodwill and willingness normally required in order for it to be deemed trustworthy? This article explores the relationship between the cancer patient, their physician, and AI chatbot in a proposed tripartite, consultative, personalized approach to shared-care in precision molecular oncology. It examines the nature of trust between human agents and machines. It also contemplates AI-enhanced technical precision in state-of-the-art cancer management, complemented by trustworthy, holistic clinical care by a physician, for each individual patient. "To what extent can the user "trust" GPT-4?" Peter Lee,1 Microsoft Research 2023.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
癌症治疗的信任三角?医生、病人和人工智能聊天机器人。
信任作为一种哲学范式,主要是人与人之间的人际关系,与依赖有所区别。一个人能信任一个不人道的、不道德的代理,比如一个大型语言模型人工智能(AI)聊天机器人,让它表现出通常需要的善意和意愿,从而被认为是值得信赖的吗?本文探讨了癌症患者、他们的医生和人工智能聊天机器人之间的关系,提出了一种三方、咨询、个性化的方法来实现精确分子肿瘤学的共享护理。它考察了人类代理人和机器之间信任的本质。它还考虑在最先进的癌症管理中使用人工智能增强的技术精度,并辅以医生对每个患者的值得信赖的整体临床护理。“用户在多大程度上可以‘信任’GPT-4?”Peter Lee,1微软研究院2023。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
7.80
自引率
2.90%
发文量
87
审稿时长
3 months
期刊介绍: Cancer Biotherapy and Radiopharmaceuticals is the established peer-reviewed journal, with over 25 years of cutting-edge content on innovative therapeutic investigations to ultimately improve cancer management. It is the only journal with the specific focus of cancer biotherapy and is inclusive of monoclonal antibodies, cytokine therapy, cancer gene therapy, cell-based therapies, and other forms of immunotherapies. The Journal includes extensive reporting on advancements in radioimmunotherapy, and the use of radiopharmaceuticals and radiolabeled peptides for the development of new cancer treatments.
期刊最新文献
EIF4A3-Induced hsa_circ_0118578 Expression Enhances the Tumorigenesis of Papillary Thyroid Cancer. GRHPR, Targeted by miR-138-5p, Inhibits the Proliferation and Metastasis of Hepatocellular Carcinoma Through PI3K/AKT Signaling Pathway. Hsa_Circ_002144 Promotes Glycolysis and Immune Escape of Breast Cancer Through miR-326/PKM Axis. Long Noncoding RNA CRNDE Promotes Gastric Cancer Progression through Targeting miR-136-5p/MIEN1. Human Biodistribution and Radiation Dosimetry of the Targeting Fibroblast Growth Factor Receptor 1-Positive Tumors Tracer [68Ga]Ga-DOTA-FGFR1-Peptide.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1